Get an alert when AGENTUS THERAPEUTICS LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2025-12-31

Overdue

Confirmation statement due

2026-07-20 (in 2mo)

Last made up 2025-07-06

Watchouts

2 items

Cash

£86K

-29.5% vs 2022

Net assets

-£16M

-12.8% vs 2022

Employees

14

+7.7% vs 2022

Profit before tax

-£2M

+6.9% vs 2022

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Name history

Renamed 2 times since incorporation

  1. AGENTUS THERAPEUTICS LIMITED 2017-10-20 → present
  2. ACTICUS LIMITED 2017-09-29 → 2017-10-20
  3. AGENTUS BIOSCIENCES LIMITED 2017-07-07 → 2017-09-29

Accounts

2-year trend · latest reflected 2023-12-31

Metric Trend 2022-12-312023-12-31
Turnover £82,000£0
Operating profit -£2,533,000-£2,359,000
Profit before tax -£2,533,000-£2,359,000
Net profit -£1,943,000-£2,305,000
Cash £122,000£86,000
Total assets less current liabilities -£14,187,000-£16,006,000
Net assets -£14,187,000-£16,006,000
Equity -£14,187,000-£16,006,000
Average employees 1314
Wages £1,073,000£1,232,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2022-12-312023-12-31
Operating margin -3089.0%
Net margin -2369.5%
Return on capital employed 17.9%14.7%
Current ratio 0.09x0.09x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
KPMG LLP
Audit opinion
Unqualified (clean)
Going concern
Material uncertainty disclosed

“We draw attention to note 1.2 to the financial statements which indicates that the company is dependent on its parent undertaking, Agenus Inc., to provide financial support for the company's operations. This financial support is dependent upon MiNK Therapeutics Inc. securing new external funding, no later March 2025. The success and timing of Agenus Inc. agreeing such new funding are uncertain. These events and conditions, along with the other matters explained in note 1.2, constitute a material uncertainty that may cast significant doubt on the company's ability to continue as a going concern.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 2 resigned

Name Role Appointed Born Nationality
TAYLOR WESSING SECRETARIES LIMITED Corporate Secretary 2017-07-07
ARMEN, Garo H. Director 2017-07-07 Jan 1953 American
Show 2 resigned officers
Name Role Appointed Resigned
HUNTSMOOR LIMITED Corporate Director 2017-07-07 2017-07-07
HUNTSMOOR NOMINEES LIMITED Corporate Director 2017-07-07 2017-07-07

Ownership

Persons with significant control

No persons with significant control on record.

Filing timeline

Last 20 of 24 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2017-10-20 RESOLUTIONS Resolution PDF
  • 2017-09-29 RESOLUTIONS Resolution
  • 2017-09-29 CONNOT Change of name notice
Date Type Category Description
2025-07-07 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-03-21 AA accounts Accounts with accounts type full
2024-07-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-07-09 CH01 officers Change person director company with change date PDF
2023-10-24 AA accounts Accounts with accounts type full
2023-07-06 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-06-30 AA accounts Accounts with accounts type full
2022-07-06 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-02-16 AA accounts Accounts with accounts type full
2021-08-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-03-08 AA accounts Accounts with accounts type full
2020-07-06 CS01 confirmation-statement Confirmation statement with no updates PDF
2019-08-27 AA accounts Accounts with accounts type full
2019-07-10 DISS40 gazette Gazette filings brought up to date
2019-07-09 CS01 confirmation-statement Confirmation statement with updates PDF
2019-06-04 GAZ1 gazette Gazette notice compulsory
2018-07-06 CS01 confirmation-statement Confirmation statement with updates PDF
2017-10-20 RESOLUTIONS resolution Resolution PDF
2017-09-29 RESOLUTIONS resolution Resolution
2017-09-29 CONNOT change-of-name Change of name notice

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
1

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2022 → FY2023 · period ending 2023-12-31 vs 2022-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page